Drug Profile
Monoclonal antibody T101-Y-90 conjugate
Alternative Names: 90Y-T101Latest Information Update: 22 Aug 2002
Price :
$50
*
At a glance
- Originator Hybritech; Nonindustrial source
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Immunosuppressants; Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Haematological malignancies
Most Recent Events
- 17 Dec 1998 New profile
- 17 Dec 1998 Phase-I clinical trials for Haematological malignancies in USA (Injection)